Bristol Myers Squibb (NYSE: BMY) - 3 Cheap Stocks That Pay Profitable Dividends - Part 2
BMS (NYSE: BMY) - 3 Cheap Stocks That Pay Profitable Dividends - Part 2
We continue the second part of our series titled 3 Inexpensive Shares that distribute Profitable Dividends with the American pharmaceutical company
Bristol Myers Squibb, headquartered in New York.
2-Bristol Myers Squibb (NYSE: BMY)
BMS is one of the big pharma stocks cheaper than water, like AbbVie, which Warren Buffett really loves these days.
Offering a solid dividend to its investors, the company has been increasing its dividend payments every year since 2010.
There is another common denominator BMS (NYSE: BMY) shares with AbbVie.
Revlimid, the company's best-selling blood disorder drug, will soon lose US patent exclusivity.
Blood pressure drug will face limited-volume generic competition from 2022.
Despite this, the blood thinner Eliquis and cancer immunotherapy, which had huge sales and broke records in the market, continue to grow significantly in sales.
In addition, Opdivo, an immunotherapy, continues to gain momentum.
In addition to all these,
BMS's series includes new products with enormous potential, especially the multiple sclerosis drug Zeposia and the anemia drug Reblozyl.
Thanks to these, it is thought that
BMS will seriously pave the way in the coming years.
You may also be interrested in: